New Novartis data in relapsing MS reinforce benefits of Kesimpta for first-line and switch patients: Basel Friday, September 20, 2024, 12:00 Hrs [IST] Novartis announced new data ...

Breakthrough Therapy Designation ... will leverage the benefits of RMAT designation, including early and more frequent interactions with the FDA, to establish an Accelerated Approval pathway for ...

Shares dropped by as much as one-quarter Thursday after the biotech shared longer-term results for a gene therapy it’s developing for wet AMD.

Personalized medicine with individually tailored therapies is becoming more and more a reality in cancer. This requires a ...

The European Medicines Agency's Committee for Medicinal Products for Human Use has recommended an update to Novo Nordisk’s ...

Stock of Applied Therapeutics, Inc. surges as FDA skips AdCom for AT-007 in galactosemia. Read more on recent developments ...

Results of these studies demonstrate that proteolipid vehicles using FAST protein overcome the limitations of current viral and non-viral genetic medicine delivery systems. Benefits of the ... Patent ...

The genetic condition is estimated to affect about 100,000 people ... “While early results are promising, it will take more time to know the full benefits.” Standard treatment options The following ...

In a world of fitness trackers built to optimize, the greatest indicators of longevity aren't what you expect.

Key Takeaways Menopause causes decreased estrogen and progesterone, leading to shorter hair growth phases and thinning, while ...

Welfare Fund and Hospital for Special Surgery (HSS), the world's leading academic medical center focused on musculoskeletal health, announced a partnership today to offer HSS Perform, a program for ...